<DOC>
	<DOCNO>NCT00790062</DOCNO>
	<brief_summary>This double-blind 3-arm randomized clinical trial determine whether high dose oxytocin regimen ( compare standard regimen ) reduce frequency uterine atony postpartum hemorrhage vaginal delivery . Uterine atony loss tone uterine musculature cause acute postpartum hemorrhage , major cause maternal mortality worldwide . Oxytocin routinely administer postpartum US effectively reduce uterine atony . The optimal dose oxytocin vaginal delivery know .</brief_summary>
	<brief_title>Oxytocin Regimen Prevent Atony Postpartum Hemorrhage During Vaginal Delivery : 3-arm RCT</brief_title>
	<detailed_description>Same brief summary . Prospective interim monitoring ( stop ) rule assess upon recruitment 2/3rds sample size 1800 . Interim review conduct 3-member DSMB January 2010 recommendation implement .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Uterine Inertia</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>&gt; 24 week , viable pregnancy , singleton twin No consent Contraindication oxytocin Antepartum fetal demise Intrapartum use concentrate oxytocin Planned cesarean DIC coagulopathy</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Uterine atony</keyword>
	<keyword>Postpartum hemorrhage</keyword>
	<keyword>clinical trial</keyword>
	<keyword>Prophylactic oxytocin</keyword>
</DOC>